January 30, 2013

Long-term effects of prostate therapies tracked

A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences were no longer significant 15 years after initial treatment.

By Vanderbilt Health News

November 15, 2012

Study tracks antioxidants’ role in prostate tumor growth

Antioxidants promote cell growth in a mouse model of prostate cancer, Vanderbilt researchers report in the journal PLoS ONE. The findings provide insight into the recent controversy regarding antioxidants and prostate cancer prevention.

By Leigh MacMillan

August 30, 2012

Vanderbilt-led study reveals racial disparities in prostate cancer care

Racial differences exist in quality surgical care, new research from VICC finds.

By Vanderbilt Health News

August 23, 2012

Gene linked to familial prostate cancer

A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows.

By Vanderbilt Health News

August 2, 2012

Proteins may point way to new prostate cancer drug targets

Two proteins that act in opposing directions – one that promotes cancer and one that suppresses cancer — regulate the same set of genes in prostate cancer, Vanderbilt-Ingram Cancer Center researchers have found.

By Vanderbilt Health News

July 24, 2012

Proteins guard against cancer spread

Targeting immune system proteins may keep prostate cancer from spreading to bone.